📢 New Review in #LiversMDPI
🧬 Digital and biological twins in cholangiocarcinoma
🩺 Fully realized medical digital twins remain unavailable, while biological twins face scalability and standardization challenges.
📖 Read More: www.mdpi.com/2673-4389/6/...
#PrecisionOncology #Cholangiocarcinoma
🧬 Digital and biological twins in cholangiocarcinoma
🩺 Fully realized medical digital twins remain unavailable, while biological twins face scalability and standardization challenges.
📖 Read More: www.mdpi.com/2673-4389/6/...
#PrecisionOncology #Cholangiocarcinoma
September 29, 2026 at 11:42 AM
📢 New Review in #LiversMDPI
🧬 Digital and biological twins in cholangiocarcinoma
🩺 Fully realized medical digital twins remain unavailable, while biological twins face scalability and standardization challenges.
📖 Read More: www.mdpi.com/2673-4389/6/...
#PrecisionOncology #Cholangiocarcinoma
🧬 Digital and biological twins in cholangiocarcinoma
🩺 Fully realized medical digital twins remain unavailable, while biological twins face scalability and standardization challenges.
📖 Read More: www.mdpi.com/2673-4389/6/...
#PrecisionOncology #Cholangiocarcinoma
📢 New Article in #LiversMDPI
🧬 TJLB was technically successful in 86 of 100 cases.
🩺 A larger HV–IVC confluence angle was associated with technical failure; the 56° cutoff remains exploratory.
📖 Read More: www.mdpi.com/2673-4389/6/...
#LiverBiopsy
🧬 TJLB was technically successful in 86 of 100 cases.
🩺 A larger HV–IVC confluence angle was associated with technical failure; the 56° cutoff remains exploratory.
📖 Read More: www.mdpi.com/2673-4389/6/...
#LiverBiopsy
September 28, 2026 at 8:22 AM
📢 New Article in #LiversMDPI
🧬 TJLB was technically successful in 86 of 100 cases.
🩺 A larger HV–IVC confluence angle was associated with technical failure; the 56° cutoff remains exploratory.
📖 Read More: www.mdpi.com/2673-4389/6/...
#LiverBiopsy
🧬 TJLB was technically successful in 86 of 100 cases.
🩺 A larger HV–IVC confluence angle was associated with technical failure; the 56° cutoff remains exploratory.
📖 Read More: www.mdpi.com/2673-4389/6/...
#LiverBiopsy
📢 New Article in #LiversMDPI
🧬 In Japanese patients with HCV, interferon-free DAA therapy was associated with early HRQoL improvements.
🩺 Generic utility scores changed little.
📖 Read More: www.mdpi.com/2673-4389/6/...
#HepatitisC #DAAs #HRQoL
🧬 In Japanese patients with HCV, interferon-free DAA therapy was associated with early HRQoL improvements.
🩺 Generic utility scores changed little.
📖 Read More: www.mdpi.com/2673-4389/6/...
#HepatitisC #DAAs #HRQoL
September 28, 2026 at 8:17 AM
📢 New Article in #LiversMDPI
🧬 In Japanese patients with HCV, interferon-free DAA therapy was associated with early HRQoL improvements.
🩺 Generic utility scores changed little.
📖 Read More: www.mdpi.com/2673-4389/6/...
#HepatitisC #DAAs #HRQoL
🧬 In Japanese patients with HCV, interferon-free DAA therapy was associated with early HRQoL improvements.
🩺 Generic utility scores changed little.
📖 Read More: www.mdpi.com/2673-4389/6/...
#HepatitisC #DAAs #HRQoL
📢 New Review in #LiversMDPI
🧬 Kaur et al. review PPAR agonists across PBC and other liver diseases.
🩺 The review covers molecular pharmacology and clinical and preclinical evidence.
📖 Read More: www.mdpi.com/2673-4389/6/...
#PPARAgonist #PBC #MASLD #Fibrosis
🧬 Kaur et al. review PPAR agonists across PBC and other liver diseases.
🩺 The review covers molecular pharmacology and clinical and preclinical evidence.
📖 Read More: www.mdpi.com/2673-4389/6/...
#PPARAgonist #PBC #MASLD #Fibrosis
September 23, 2026 at 10:28 AM
📢 New Review in #LiversMDPI
🧬 Kaur et al. review PPAR agonists across PBC and other liver diseases.
🩺 The review covers molecular pharmacology and clinical and preclinical evidence.
📖 Read More: www.mdpi.com/2673-4389/6/...
#PPARAgonist #PBC #MASLD #Fibrosis
🧬 Kaur et al. review PPAR agonists across PBC and other liver diseases.
🩺 The review covers molecular pharmacology and clinical and preclinical evidence.
📖 Read More: www.mdpi.com/2673-4389/6/...
#PPARAgonist #PBC #MASLD #Fibrosis
📢 New Article in #LiversMDPI
🧬 Cardoso et al. compared oral and IP acetaminophen administration in mouse models of ALF.
🩺 Effective doses: 500 mg/kg oral; 400 mg/kg IP.
📖 Read More: www.mdpi.com/2673-4389/6/...
#Acetaminophen #AcuteLiverFailure #PreclinicalModels
🧬 Cardoso et al. compared oral and IP acetaminophen administration in mouse models of ALF.
🩺 Effective doses: 500 mg/kg oral; 400 mg/kg IP.
📖 Read More: www.mdpi.com/2673-4389/6/...
#Acetaminophen #AcuteLiverFailure #PreclinicalModels
September 23, 2026 at 10:18 AM
📢 New Article in #LiversMDPI
🧬 Cardoso et al. compared oral and IP acetaminophen administration in mouse models of ALF.
🩺 Effective doses: 500 mg/kg oral; 400 mg/kg IP.
📖 Read More: www.mdpi.com/2673-4389/6/...
#Acetaminophen #AcuteLiverFailure #PreclinicalModels
🧬 Cardoso et al. compared oral and IP acetaminophen administration in mouse models of ALF.
🩺 Effective doses: 500 mg/kg oral; 400 mg/kg IP.
📖 Read More: www.mdpi.com/2673-4389/6/...
#Acetaminophen #AcuteLiverFailure #PreclinicalModels
📢 Editor’s Choice in #LiversMDPI
🧪 Pyka et al. developed FibroScan® cap geometries for non-invasive liver assessment using a pig model.
🧬 In vivo results showed high agreement with the numerical model.
📖 More: brnw.ch/21x5qSt
#Elastography #PigLiver #FibroScan
🧪 Pyka et al. developed FibroScan® cap geometries for non-invasive liver assessment using a pig model.
🧬 In vivo results showed high agreement with the numerical model.
📖 More: brnw.ch/21x5qSt
#Elastography #PigLiver #FibroScan
September 23, 2026 at 10:09 AM
📢 Editor’s Choice in #LiversMDPI
🧪 Pyka et al. developed FibroScan® cap geometries for non-invasive liver assessment using a pig model.
🧬 In vivo results showed high agreement with the numerical model.
📖 More: brnw.ch/21x5qSt
#Elastography #PigLiver #FibroScan
🧪 Pyka et al. developed FibroScan® cap geometries for non-invasive liver assessment using a pig model.
🧬 In vivo results showed high agreement with the numerical model.
📖 More: brnw.ch/21x5qSt
#Elastography #PigLiver #FibroScan
📢 Call for Reading in #LiversMDPI
🔬 Villanueva Raisman et al. quantified 108 proteins in 2 µL of plasma.
🧬 Potential biomarkers for stratifying liver fibrosis were identified.
📖 Read More: brnw.ch/21x5oWo
#Fibrosis #Proteomics #MassSpectrometry
🔬 Villanueva Raisman et al. quantified 108 proteins in 2 µL of plasma.
🧬 Potential biomarkers for stratifying liver fibrosis were identified.
📖 Read More: brnw.ch/21x5oWo
#Fibrosis #Proteomics #MassSpectrometry
September 22, 2026 at 10:48 AM
📢 Call for Reading in #LiversMDPI
🔬 Villanueva Raisman et al. quantified 108 proteins in 2 µL of plasma.
🧬 Potential biomarkers for stratifying liver fibrosis were identified.
📖 Read More: brnw.ch/21x5oWo
#Fibrosis #Proteomics #MassSpectrometry
🔬 Villanueva Raisman et al. quantified 108 proteins in 2 µL of plasma.
🧬 Potential biomarkers for stratifying liver fibrosis were identified.
📖 Read More: brnw.ch/21x5oWo
#Fibrosis #Proteomics #MassSpectrometry
📢 New Review in #LiversMDPI
🧬 Vignone et al. review PSC-IBD epidemiology, pathophysiology, and management.
🩺 PSC-IBD is linked to increased colorectal cancer and cholangiocarcinoma risks.
📖 Read More: www.mdpi.com/2673-4389/6/...
#PSC #IBD #ColorectalCancer
🧬 Vignone et al. review PSC-IBD epidemiology, pathophysiology, and management.
🩺 PSC-IBD is linked to increased colorectal cancer and cholangiocarcinoma risks.
📖 Read More: www.mdpi.com/2673-4389/6/...
#PSC #IBD #ColorectalCancer
September 22, 2026 at 10:41 AM
📢 New Review in #LiversMDPI
🧬 Vignone et al. review PSC-IBD epidemiology, pathophysiology, and management.
🩺 PSC-IBD is linked to increased colorectal cancer and cholangiocarcinoma risks.
📖 Read More: www.mdpi.com/2673-4389/6/...
#PSC #IBD #ColorectalCancer
🧬 Vignone et al. review PSC-IBD epidemiology, pathophysiology, and management.
🩺 PSC-IBD is linked to increased colorectal cancer and cholangiocarcinoma risks.
📖 Read More: www.mdpi.com/2673-4389/6/...
#PSC #IBD #ColorectalCancer
📢 New Review in #LiversMDPI
🧬 Jones et al. examine HCC complexity and therapeutic challenges, focusing on HuR.
🩺 Preclinical evidence supports HuR inhibition as a potential strategy in HCC.
📖 Read More: www.mdpi.com/2673-4389/6/...
#HCC #HuR #TherapeuticResistance
🧬 Jones et al. examine HCC complexity and therapeutic challenges, focusing on HuR.
🩺 Preclinical evidence supports HuR inhibition as a potential strategy in HCC.
📖 Read More: www.mdpi.com/2673-4389/6/...
#HCC #HuR #TherapeuticResistance
September 22, 2026 at 10:34 AM
📢 New Review in #LiversMDPI
🧬 Jones et al. examine HCC complexity and therapeutic challenges, focusing on HuR.
🩺 Preclinical evidence supports HuR inhibition as a potential strategy in HCC.
📖 Read More: www.mdpi.com/2673-4389/6/...
#HCC #HuR #TherapeuticResistance
🧬 Jones et al. examine HCC complexity and therapeutic challenges, focusing on HuR.
🩺 Preclinical evidence supports HuR inhibition as a potential strategy in HCC.
📖 Read More: www.mdpi.com/2673-4389/6/...
#HCC #HuR #TherapeuticResistance
📢 New Article in #LiversMDPI
🧬 Galla et al. tested a nutraceutical in a gut–pancreas–liver model.
🩺 It reduced lipid accumulation and increased bile acid production.
📖 Read More: www.mdpi.com/2673-4389/6/...
#MASLD #Nutraceuticals #Probiotics
🧬 Galla et al. tested a nutraceutical in a gut–pancreas–liver model.
🩺 It reduced lipid accumulation and increased bile acid production.
📖 Read More: www.mdpi.com/2673-4389/6/...
#MASLD #Nutraceuticals #Probiotics
September 21, 2026 at 12:41 PM
📢 New Article in #LiversMDPI
🧬 Galla et al. tested a nutraceutical in a gut–pancreas–liver model.
🩺 It reduced lipid accumulation and increased bile acid production.
📖 Read More: www.mdpi.com/2673-4389/6/...
#MASLD #Nutraceuticals #Probiotics
🧬 Galla et al. tested a nutraceutical in a gut–pancreas–liver model.
🩺 It reduced lipid accumulation and increased bile acid production.
📖 Read More: www.mdpi.com/2673-4389/6/...
#MASLD #Nutraceuticals #Probiotics
📢 New Review in #LiversMDPI
🧬 Yuquimpo et al. describe hCLS macrophage subtypes in steatotic liver disease.
🩺 Most hCLS cells are variations of lipid-associated macrophages.
📖 Read More: www.mdpi.com/2673-4389/6/...
#hCLS #Macrophages #KupfferCells
🧬 Yuquimpo et al. describe hCLS macrophage subtypes in steatotic liver disease.
🩺 Most hCLS cells are variations of lipid-associated macrophages.
📖 Read More: www.mdpi.com/2673-4389/6/...
#hCLS #Macrophages #KupfferCells
September 21, 2026 at 12:33 PM
📢 New Review in #LiversMDPI
🧬 Yuquimpo et al. describe hCLS macrophage subtypes in steatotic liver disease.
🩺 Most hCLS cells are variations of lipid-associated macrophages.
📖 Read More: www.mdpi.com/2673-4389/6/...
#hCLS #Macrophages #KupfferCells
🧬 Yuquimpo et al. describe hCLS macrophage subtypes in steatotic liver disease.
🩺 Most hCLS cells are variations of lipid-associated macrophages.
📖 Read More: www.mdpi.com/2673-4389/6/...
#hCLS #Macrophages #KupfferCells
📢 Call for Reading in #LiversMDPI
🔬 Fennell et al. analyzed 59 chronic MTX users who underwent VCTE.
🧬 MetS was associated with liver injury, independent of cumulative MTX dosage.
📖 More: brnw.ch/21x5mTh
#Methotrexate #MetabolicSyndrome #LiverInjury
🔬 Fennell et al. analyzed 59 chronic MTX users who underwent VCTE.
🧬 MetS was associated with liver injury, independent of cumulative MTX dosage.
📖 More: brnw.ch/21x5mTh
#Methotrexate #MetabolicSyndrome #LiverInjury
September 21, 2026 at 12:29 PM
📢 Call for Reading in #LiversMDPI
🔬 Fennell et al. analyzed 59 chronic MTX users who underwent VCTE.
🧬 MetS was associated with liver injury, independent of cumulative MTX dosage.
📖 More: brnw.ch/21x5mTh
#Methotrexate #MetabolicSyndrome #LiverInjury
🔬 Fennell et al. analyzed 59 chronic MTX users who underwent VCTE.
🧬 MetS was associated with liver injury, independent of cumulative MTX dosage.
📖 More: brnw.ch/21x5mTh
#Methotrexate #MetabolicSyndrome #LiverInjury
📢 Join the Early Career Editorial Board of #LiversMdpi
🎓 Livers is recruiting early-career researchers worldwide to join its ECEB and contribute their academic insights and professional expertise.
🔗 More Information: brnw.ch/21x48Mr
#Hepatology #AcademicRecruitment #EarlyCareerResearcher
🎓 Livers is recruiting early-career researchers worldwide to join its ECEB and contribute their academic insights and professional expertise.
🔗 More Information: brnw.ch/21x48Mr
#Hepatology #AcademicRecruitment #EarlyCareerResearcher
September 18, 2026 at 10:08 AM
📢 Join the Early Career Editorial Board of #LiversMdpi
🎓 Livers is recruiting early-career researchers worldwide to join its ECEB and contribute their academic insights and professional expertise.
🔗 More Information: brnw.ch/21x48Mr
#Hepatology #AcademicRecruitment #EarlyCareerResearcher
🎓 Livers is recruiting early-career researchers worldwide to join its ECEB and contribute their academic insights and professional expertise.
🔗 More Information: brnw.ch/21x48Mr
#Hepatology #AcademicRecruitment #EarlyCareerResearcher
📢 Livers #Exceptional #Reviewers List 2026
🎉 Congratulations to our Q2 outstanding reviewer, Dr. Deborah Jean Verran of Ramsay Healthcare, Sydney, Australia!
📖 More details: www.mdpi.com/journal/live...
#Livers #PeerReview #ExceptionalReviewers #LiversMDPI
🎉 Congratulations to our Q2 outstanding reviewer, Dr. Deborah Jean Verran of Ramsay Healthcare, Sydney, Australia!
📖 More details: www.mdpi.com/journal/live...
#Livers #PeerReview #ExceptionalReviewers #LiversMDPI
September 17, 2026 at 11:56 AM
📢 Livers #Exceptional #Reviewers List 2026
🎉 Congratulations to our Q2 outstanding reviewer, Dr. Deborah Jean Verran of Ramsay Healthcare, Sydney, Australia!
📖 More details: www.mdpi.com/journal/live...
#Livers #PeerReview #ExceptionalReviewers #LiversMDPI
🎉 Congratulations to our Q2 outstanding reviewer, Dr. Deborah Jean Verran of Ramsay Healthcare, Sydney, Australia!
📖 More details: www.mdpi.com/journal/live...
#Livers #PeerReview #ExceptionalReviewers #LiversMDPI
📢 New Issue in #LiversMDPI
📚 Volume 6, Issue 4 is now online with 27 articles
⭐ Cover Story: Hepatic crown-like structures, cell heterogeneity, and their role in steatotic liver diseases
🔗 Full issue here: mdpi.com/2673-4389/6/4
#Hepatology #LiverResearch #SteatoticLiver
📚 Volume 6, Issue 4 is now online with 27 articles
⭐ Cover Story: Hepatic crown-like structures, cell heterogeneity, and their role in steatotic liver diseases
🔗 Full issue here: mdpi.com/2673-4389/6/4
#Hepatology #LiverResearch #SteatoticLiver
September 16, 2026 at 7:55 AM
📢 New Issue in #LiversMDPI
📚 Volume 6, Issue 4 is now online with 27 articles
⭐ Cover Story: Hepatic crown-like structures, cell heterogeneity, and their role in steatotic liver diseases
🔗 Full issue here: mdpi.com/2673-4389/6/4
#Hepatology #LiverResearch #SteatoticLiver
📚 Volume 6, Issue 4 is now online with 27 articles
⭐ Cover Story: Hepatic crown-like structures, cell heterogeneity, and their role in steatotic liver diseases
🔗 Full issue here: mdpi.com/2673-4389/6/4
#Hepatology #LiverResearch #SteatoticLiver
📢 Editor’s Choice in #LiversMDPI
🧬 Pedersen et al. used untargeted proteomics on paired visceral adipose and liver biopsies in obesity, #MASLD and #MASH
🩺 Proteomes in both tissues were affected more by #obesity than MASLD severity
📖 More: brnw.ch/21x5kUD
#VisceralAdiposeTissue #LiverTissue
🧬 Pedersen et al. used untargeted proteomics on paired visceral adipose and liver biopsies in obesity, #MASLD and #MASH
🩺 Proteomes in both tissues were affected more by #obesity than MASLD severity
📖 More: brnw.ch/21x5kUD
#VisceralAdiposeTissue #LiverTissue
September 16, 2026 at 7:35 AM
📢 Editor’s Choice in #LiversMDPI
🧬 Pedersen et al. used untargeted proteomics on paired visceral adipose and liver biopsies in obesity, #MASLD and #MASH
🩺 Proteomes in both tissues were affected more by #obesity than MASLD severity
📖 More: brnw.ch/21x5kUD
#VisceralAdiposeTissue #LiverTissue
🧬 Pedersen et al. used untargeted proteomics on paired visceral adipose and liver biopsies in obesity, #MASLD and #MASH
🩺 Proteomes in both tissues were affected more by #obesity than MASLD severity
📖 More: brnw.ch/21x5kUD
#VisceralAdiposeTissue #LiverTissue
📢Only one day left for #LiversMDPI Webinar | Biomarkers in Drug-Induced Liver Injury
📅16 Sept 2026 |
⏰3 pm CEST | 9 am EDT
🔗Final Day - Free Registration: brnw.ch/21x5uSr
📖 More Information at: brnw.ch/21x5uPe
#DILI #Biomarkers #LiverInjury #Hepatology
📅16 Sept 2026 |
⏰3 pm CEST | 9 am EDT
🔗Final Day - Free Registration: brnw.ch/21x5uSr
📖 More Information at: brnw.ch/21x5uPe
#DILI #Biomarkers #LiverInjury #Hepatology
📢 One week left for #LiversMdpi Webinar: Biomarkers in #DILI
🎓Event Chair: Prof. Dr. Hartmut Jaeschke
📅16 Sept | 3 pm CEST | 9 am EDT
🔗Free Registration: brnw.ch/21x5uS4
📖 More Information: brnw.ch/21x5uS5
#Hepatitis #OpenAccess
🎓Event Chair: Prof. Dr. Hartmut Jaeschke
📅16 Sept | 3 pm CEST | 9 am EDT
🔗Free Registration: brnw.ch/21x5uS4
📖 More Information: brnw.ch/21x5uS5
#Hepatitis #OpenAccess
September 15, 2026 at 9:37 AM
📢Only one day left for #LiversMDPI Webinar | Biomarkers in Drug-Induced Liver Injury
📅16 Sept 2026 |
⏰3 pm CEST | 9 am EDT
🔗Final Day - Free Registration: brnw.ch/21x5uSr
📖 More Information at: brnw.ch/21x5uPe
#DILI #Biomarkers #LiverInjury #Hepatology
📅16 Sept 2026 |
⏰3 pm CEST | 9 am EDT
🔗Final Day - Free Registration: brnw.ch/21x5uSr
📖 More Information at: brnw.ch/21x5uPe
#DILI #Biomarkers #LiverInjury #Hepatology
📢 Editor's Choice
📌 Article in #LiversMDPI
🧬 Idowu et al. examined chronic cholesterol elevation in NTCP- and OCT1-expressing cells.
🩺 Cholesterol increased cellular levels ~2-fold and decreased NTCP- and OCT1-mediated transport.
📖 More: www.mdpi.com/2673-4389/5/...
#NTCP #OCT1 #Cholesterol
📌 Article in #LiversMDPI
🧬 Idowu et al. examined chronic cholesterol elevation in NTCP- and OCT1-expressing cells.
🩺 Cholesterol increased cellular levels ~2-fold and decreased NTCP- and OCT1-mediated transport.
📖 More: www.mdpi.com/2673-4389/5/...
#NTCP #OCT1 #Cholesterol
September 14, 2026 at 12:02 PM
📢 Editor's Choice
📌 Article in #LiversMDPI
🧬 Idowu et al. examined chronic cholesterol elevation in NTCP- and OCT1-expressing cells.
🩺 Cholesterol increased cellular levels ~2-fold and decreased NTCP- and OCT1-mediated transport.
📖 More: www.mdpi.com/2673-4389/5/...
#NTCP #OCT1 #Cholesterol
📌 Article in #LiversMDPI
🧬 Idowu et al. examined chronic cholesterol elevation in NTCP- and OCT1-expressing cells.
🩺 Cholesterol increased cellular levels ~2-fold and decreased NTCP- and OCT1-mediated transport.
📖 More: www.mdpi.com/2673-4389/5/...
#NTCP #OCT1 #Cholesterol
📢 Call for Reading in #LiversMDPI
🧬 Fortier et al. describe a secondary perfusion model for livers declined after normothermic machine perfusion
🩺 Marginal donor case confirms predicted dysfunction
📖 More: brnw.ch/21x5jpM
#OrganDiscard #LiverTransplantation
🧬 Fortier et al. describe a secondary perfusion model for livers declined after normothermic machine perfusion
🩺 Marginal donor case confirms predicted dysfunction
📖 More: brnw.ch/21x5jpM
#OrganDiscard #LiverTransplantation
September 14, 2026 at 11:55 AM
📢 Call for Reading in #LiversMDPI
🧬 Fortier et al. describe a secondary perfusion model for livers declined after normothermic machine perfusion
🩺 Marginal donor case confirms predicted dysfunction
📖 More: brnw.ch/21x5jpM
#OrganDiscard #LiverTransplantation
🧬 Fortier et al. describe a secondary perfusion model for livers declined after normothermic machine perfusion
🩺 Marginal donor case confirms predicted dysfunction
📖 More: brnw.ch/21x5jpM
#OrganDiscard #LiverTransplantation
📢 Call for Reading | Review in #LiversMDPI
🧬 Palliative care in ESLD remains underutilized and faces barriers.
🩺 The review highlights improved symptom control and quality of life.
📖 More: www.mdpi.com/2673-4389/5/...
#PalliativeCare #ESLD #Hepatology #HepatocellularCarcinoma
🧬 Palliative care in ESLD remains underutilized and faces barriers.
🩺 The review highlights improved symptom control and quality of life.
📖 More: www.mdpi.com/2673-4389/5/...
#PalliativeCare #ESLD #Hepatology #HepatocellularCarcinoma
September 11, 2026 at 7:42 AM
📢 Call for Reading | Review in #LiversMDPI
🧬 Palliative care in ESLD remains underutilized and faces barriers.
🩺 The review highlights improved symptom control and quality of life.
📖 More: www.mdpi.com/2673-4389/5/...
#PalliativeCare #ESLD #Hepatology #HepatocellularCarcinoma
🧬 Palliative care in ESLD remains underutilized and faces barriers.
🩺 The review highlights improved symptom control and quality of life.
📖 More: www.mdpi.com/2673-4389/5/...
#PalliativeCare #ESLD #Hepatology #HepatocellularCarcinoma
📢 Call for Reading in #LiversMDPI
🧬 Resistance training improved VO2, distance & strength.
🩺 Vellatt & Soldera review on sarcopenia.
📖 More: brnw.ch/21x5gLN
#cirrhosis #sarcopenia #resistancetraining
🧬 Resistance training improved VO2, distance & strength.
🩺 Vellatt & Soldera review on sarcopenia.
📖 More: brnw.ch/21x5gLN
#cirrhosis #sarcopenia #resistancetraining
September 11, 2026 at 7:31 AM
📢 Call for Reading in #LiversMDPI
🧬 Resistance training improved VO2, distance & strength.
🩺 Vellatt & Soldera review on sarcopenia.
📖 More: brnw.ch/21x5gLN
#cirrhosis #sarcopenia #resistancetraining
🧬 Resistance training improved VO2, distance & strength.
🩺 Vellatt & Soldera review on sarcopenia.
📖 More: brnw.ch/21x5gLN
#cirrhosis #sarcopenia #resistancetraining
📢 Editor’s Choice
📌 Review in #LiversMDPI
🧬 Oral biguanides reach high intestinal levels and reduce glucose absorption.
🩺 The review describes side effects and fluid loss.
📖 Learn more: brnw.ch/21x5Axl
#Biguanides #IntestinalGlucoseExcretion #Diabetes #KidneyInjury
📌 Review in #LiversMDPI
🧬 Oral biguanides reach high intestinal levels and reduce glucose absorption.
🩺 The review describes side effects and fluid loss.
📖 Learn more: brnw.ch/21x5Axl
#Biguanides #IntestinalGlucoseExcretion #Diabetes #KidneyInjury
September 10, 2026 at 12:38 PM
📢 Editor’s Choice
📌 Review in #LiversMDPI
🧬 Oral biguanides reach high intestinal levels and reduce glucose absorption.
🩺 The review describes side effects and fluid loss.
📖 Learn more: brnw.ch/21x5Axl
#Biguanides #IntestinalGlucoseExcretion #Diabetes #KidneyInjury
📌 Review in #LiversMDPI
🧬 Oral biguanides reach high intestinal levels and reduce glucose absorption.
🩺 The review describes side effects and fluid loss.
📖 Learn more: brnw.ch/21x5Axl
#Biguanides #IntestinalGlucoseExcretion #Diabetes #KidneyInjury
📢 Call for Reading in #LiversMDPI
🧬 Caringi et al. evaluated 35 robotic liver resections for breast cancer liver metastasis
🩺 11.44% complication rate, 4.65 mean hospital stay, and 2.85% 90-day mortality
📖 More: brnw.ch/21x5eRz
#BreastCancer #RoboticSurgery
🧬 Caringi et al. evaluated 35 robotic liver resections for breast cancer liver metastasis
🩺 11.44% complication rate, 4.65 mean hospital stay, and 2.85% 90-day mortality
📖 More: brnw.ch/21x5eRz
#BreastCancer #RoboticSurgery
September 10, 2026 at 12:26 PM
📢 Call for Reading in #LiversMDPI
🧬 Caringi et al. evaluated 35 robotic liver resections for breast cancer liver metastasis
🩺 11.44% complication rate, 4.65 mean hospital stay, and 2.85% 90-day mortality
📖 More: brnw.ch/21x5eRz
#BreastCancer #RoboticSurgery
🧬 Caringi et al. evaluated 35 robotic liver resections for breast cancer liver metastasis
🩺 11.44% complication rate, 4.65 mean hospital stay, and 2.85% 90-day mortality
📖 More: brnw.ch/21x5eRz
#BreastCancer #RoboticSurgery
📢 Editor's Choice
📌Review in #LiversMDPI
🧬 Mihăilă et al. review #liver and vascular involvement in Philadelphia-negative chronic #myeloproliferative neoplasms
🩺 #MPNs are linked to increased thrombotic risk, particularly splanchnic #thrombosis
📖 More here: brnw.ch/21x5yxt
#JAK2V617F
📌Review in #LiversMDPI
🧬 Mihăilă et al. review #liver and vascular involvement in Philadelphia-negative chronic #myeloproliferative neoplasms
🩺 #MPNs are linked to increased thrombotic risk, particularly splanchnic #thrombosis
📖 More here: brnw.ch/21x5yxt
#JAK2V617F
September 9, 2026 at 12:50 PM
📢 Editor's Choice
📌Review in #LiversMDPI
🧬 Mihăilă et al. review #liver and vascular involvement in Philadelphia-negative chronic #myeloproliferative neoplasms
🩺 #MPNs are linked to increased thrombotic risk, particularly splanchnic #thrombosis
📖 More here: brnw.ch/21x5yxt
#JAK2V617F
📌Review in #LiversMDPI
🧬 Mihăilă et al. review #liver and vascular involvement in Philadelphia-negative chronic #myeloproliferative neoplasms
🩺 #MPNs are linked to increased thrombotic risk, particularly splanchnic #thrombosis
📖 More here: brnw.ch/21x5yxt
#JAK2V617F
📢 Editor's Choice:
📌 Review in #LiversMDPI
🧬 Dr. Ananda Baral reviews albumin synthesis, transport, and modifications.
🩺 Dysregulation links to hepatic, cardiac, renal diseases.
📖 More: brnw.ch/21x5d5g
#Albumin #Hepatocytes
📌 Review in #LiversMDPI
🧬 Dr. Ananda Baral reviews albumin synthesis, transport, and modifications.
🩺 Dysregulation links to hepatic, cardiac, renal diseases.
📖 More: brnw.ch/21x5d5g
#Albumin #Hepatocytes
September 9, 2026 at 12:37 PM
📢 Editor's Choice:
📌 Review in #LiversMDPI
🧬 Dr. Ananda Baral reviews albumin synthesis, transport, and modifications.
🩺 Dysregulation links to hepatic, cardiac, renal diseases.
📖 More: brnw.ch/21x5d5g
#Albumin #Hepatocytes
📌 Review in #LiversMDPI
🧬 Dr. Ananda Baral reviews albumin synthesis, transport, and modifications.
🩺 Dysregulation links to hepatic, cardiac, renal diseases.
📖 More: brnw.ch/21x5d5g
#Albumin #Hepatocytes